Cure Autism Now | AGRE Catalog: Autism Genetic Resource Exchange (PDF Avail.) | October 2000 #AutisticHistory

[Note: Shared for #AutisticHistory archive purposes. This is NOT An Autistic Ally.]

The full report is available on the AGRE catalog pdf. Below is the introduction.

October, 2000
Cure Autism Now
Autism Genetic Resource Exchange Re: AGRE Catalog

Dear Colleagues:

It is a great pleasure to be able to introduce our second edition of the catalog for the Autism Genetic Resource Exchange (AGRE), an unprecedented resource for the study of autism genetics. There is no ques- tion that complex neuropsychiatric diseases such as autism are best approached by collaborative research efforts that pool large sample numbers to obtain sufficient power and meaningful results, rather than groups working independently with smaller samples. The goal of AGRE is to facilitate more rapid progress in identi- fication of the genetic causes of autism and autism spectrum disorders by promoting sharing and collabora- tion. This collection of a large set of multiplex families is a first step in that direction.

AGRE is a DNA repository and family registry, housing a database of genotypes and phenotypic informa- tion available to the entire scientific community. In this second edition of the AGRE catalog, there are a total of 225 families currently available for distribution, 197 of which are multiplex and 144 of these who have not been part of any other genetic study, to the best of our knowledge. As they become available, additional family pedigrees will be posted on our online catalog, which based on the expanding nature of the resource, provides the most up-to-date availability of pedigrees and biomaterials ( Cell lines have been established and quality checked for each individual in this collection.

The diagnosis of autism or P.D.D. has been made using the standard Autism Diagnostic Interview—Revised (ADI-R) algorithm, and all raters have been trained and validated (see accompanying letter from Dr. Catherine Lord). Most of these families have had extensive evaluations by a variety of pediatricians, psychiatrists and other neurodevelopmental specialists. However, these evaluations are not uniform. In order to make this resource available to the scientific community as rapidly as possible, we have chosen to characterize these families in a tier-wise fashion. All of this information will be entered into a centralized database and made available through the AGRE Web site, using the appropriate security precautions, to participating researchers.

ADI information (including regression and verbal vs. non-verbal ratings), family structure, and ethnicity data are available on all catalog families. Autism Diagnostic Observation Schedule (ADOS) evaluations, uni- form pediatric neurological, neurobehavioral and genetic evaluations are currently available on about 50 fam- ilies in this catalog. These data will continue to be collected over the next 12–18 months on the remainder of these catalog families. In addition, an extensive questionnaire regarding a large variety of phenotypic and family history issues, potentially valuable to those attempting to define sub-phenotypes for genetic analysis, will soon be completed.

To date, 200 of these 225 catalog families have been screened for Fragile X by PCR by Dr. Ted Brown. Two families of the 200 families have tested Fragile X positive. In order to rule out other chromosomal abnormal- ities, karyotyping is currently being conducted on the entire catalog family collection, as well as FISH analy- sis, in the laboratory of Dr. David Ledbetter. Another interesting feature of this collection is the high number of multiple births. Some investigators may not want to use this subgroup of patients for genetic studies because of potential environmental confounders. However, these samples are in the catalog and are available. Zygosity has been confirmed by genotyping.

We expect to continue adding families to the AGRE collection over the next few years with the goal of including more than 500 families. We will also continue to collect and compile extensive genotypic and phe- notypic information which can be accessed through AGRE online databases. Data on the existing collection are now available online in a secure Web-based format that investigators can query.

There are several ways to obtain access to the AGRE samples. Scientists and others must apply to the Steering Committee for access. When approved, orders are sent to the AGRE resource at HBDI. DNA and clinical information will be available to any credible scientist for genetic analysis, ranging from whole genome screens to candidate gene analysis. Those who contribute their multiplex families to the resource will be given an equal number of families for analysis, free of cost. Additional multiplex families will be available for a nominal fee, roughly equal to HBDI’s cost, to any interested qualified researcher, whether or not they con- tribute to the gene bank. Thus, those without any previous clinical or laboratory experience in the field of autism will have equal access to these samples for pursuing studies that they believe may lead to a better understanding of autism.

An initial genome screen has been completed on 130 of these 225 families using the James Weber version 6 microsatellite marker set with additional markers selected from the Marshfield Database by Dr. Conrad Gilliam at Columbia University. The genotypic database is available to approved researchers at Web site

Given the three groups of whole genome scans that have recently been completed in the first round of efforts to identify chromosomal loci contributing to autism, the availability of this resource is particularly important for the replication of these results and for helping to narrow loci. Since these samples are available to any qualified researcher at a fraction of the cost that it actually would cost them to ascertain an equal number, this provides a cost-effective and efficient way to replicate and expand on these initial studies. In addition, we hope that it will aid in fostering collaboration between groups working in autism genetics and perhaps, eventually, a central repository and database where information and samples are shared.

We welcome your interest and participation in AGRE. Please feel free to contact any of the members of the AGRE Steering Committee if any questions about this resource remain. Please direct any inquiries to Janice Sowinski, HBDI Division Director, 800-345-4234, Ext. 232, at the Human Biological Data Interchange (HBDI), whose staff provide the day-to-day administration of AGRE, or to Cure Autism Now at 323-549-0500, which provides funding and oversight for this resource.

Sincerely yours,

Daniel H. Geschwind, M.D., Ph.D., for the AGRE

scientific advisory board:
Bruce Miller, M.D.
W. Ted Brown, M.D., Ph.D. Joseph Buxbaum, Ph.D Edwin Cook, M.D.
T. Conrad Gilliam, Ph.D. David Greenberg, Ph.D. David Ledbetter, Ph.D.
Stanley F. Nelson, M.D. Carol Sprouse, E.D. Jerome Rotter, M.D. Gerard Schellenberg, Ph.D. Rudolph Tanzi, Ph.D.
Kirk Wilhelmsen, M.D., Ph.D.

More With Cure Autism Now

Cure Autism Now: POLITICAL ACTION ALERT | May 13, 2001

POLITICAL ACTION ALERT – Sunday, May 13, 2001 We need the immediate help of everyone in the developmentally disabled community! A group of families have recently begun an effort to get some tax relief for the more than three million families in the US who have children with developmental disabilities. The basic idea is to…

Cure Autism Now: Antibiotics for Autism | December 2000

Antibiotics for Autism Ivanhoe Broadcast News December 2000 Antibiotics for Autism Antibiotics for AutismTelevision News Service/Medical BreakthroughsIvanhoe Broadcast News, Inc. December 2000 (Ivanhoe Newswire) — According to the National Institute of Mental Health, about 1 in every 500 people has autism — a developmental disorder that affects language and social skills. For years it’s been largely…

Cure Autism Now Parent Advisory Board as of June 1996

The CAN Parent Advisory Board The CAN international parent board will monitor research efforts from around the world, circulate the latest findings among the scientific work group, and coordinate fundraising. CAN believes that it is the interaction between concerned parents and researchers in the field that will help keep motivation high and the pace of…


Something went wrong. Please refresh the page and/or try again.

More With AGRE

Cure Autism Now | The Autism Genetic Resource Exchange | August 1996

The Autism Genetic Resource Exchange A time for work, a time for hope, a time for gathering together Some little known facts about autism: Autism is not rare. Autism is the third most common developmental disorder. Two out of every 1000 children born in the US will be on the autistic spectrum. Autism currently effects…

Cure Autism Now: The Advancement in Pediatric Autism Research Act | 1999

S.2263HR.4203 This historic legislation is designed to greatly increase funding and awareness of autism, a severe neurological disorder that currently affects over 400,000 individuals in the United States alone, and one in every 500 children born today, at an annual national cost of over $13.3 billion dollars. Sponsored by: The main points of the legislation:…

Families Make the Critical Difference in the Pace of Autism Research | March-April 1997 

Families Make the Critical Difference in the Pace of Autism Research The Advocate March-April 1997 by: Portia Iversen & Jonathan Shestack    Families of people with autism have taken the lead in genetic research by forming AGRE, the Autism Genetic Resource Exchange. This is the world’s first truly collaborative gene bank for autism. It is administered with the highest…

Cure Autism Now(CAN) Funds research in search of answers | Fall/Winter 1997

Cure Autism Now(CAN) Funds research in search of answers COSAC Outreach, Fall/Winter 1997  by Jon Shestack     The Cure Autism Now (CAN) foundation was established in California almost two years ago by a group of parents, clinicians and researchers. In looking for answers for their own children and patients, they were shocked to find how little…


Something went wrong. Please refresh the page and/or try again.

More With Daniel Geschwind

Cure Autism Now Board Of Directors, Honorary Board, AGRE Steering Committee & More | 2000 #AutisticHistory

DIRECTORS THE CAN BOARD OF DIRECTORS Portia E. Iversen  President (parent) Jonathan Shestack Vice President, Treasurer (parent) Ricki Robinson, M.D.  Medical Liaison (parent) Ellen Bolte  Secretary (parent) Sallie Bernard   Board Member (parent)  Andrea Bertrand  Board Member (parent) Anthony Edwards  Board Member  Elizabeth Emken  Board Member (parent) Nanci Fredkin  Board Member George Jones  Board Member (parent) Jonathan Kaunitz, M.D.  Board Member (parent) Marianne Lynch  Board Member (parent)  Jerome Shestack, Esq  Board member (grandparent)  THE CAN HONORARY BOARD…

#BoycottSpectrum10K | Autistics & Allies Protesting Spectrum 10K Get Heard Worldwide & It’s About Damn Time | August – November 2021 | #HandsOffMyDNA #NothingAboutUsWithoutUs

Autistic campaigners’ anger over Spectrum 10K protest lock-out and ‘scare tactics’ By John Pring on 4th November 2021 Autistic campaigners protested for hours outside the research centre at the centre of a £3 million study that they believe could be used for the purposes of eugenics. They were forced to protest outside the entrance, beside a main road,…


Something went wrong. Please refresh the page and/or try again.


Autistic people have fought the inclusion of ABA in therapy for us since before Autism Speaks, and other non-Autistic-led autism organizations, started lobbying legislation to get it covered by insurances and Medicaid. 

ABA is a myth originally sold to parents that it would keep their Autistic child out of an institution. Today, parents are told that with early intervention therapy their child will either be less Autistic or no longer Autistic by elementary school, and can be mainstreamed in typical education classes. ABA is very expensive to pay out of pocket. Essentially, Autism Speaks has justified the big price tag up front will offset the overall burden on resources for an Autistic’s lifetime. The recommendation for this therapy is 40 hours a week for children and toddlers.

The original study that showed the success rate of ABA to be at 50% has never been replicated. In fact, the study of ABA by United States Department of Defense was denounced as a failure. Not just once, but multiple times. Simply stated: ABA doesn’t workIn study after repeated study: ABA (conversion therapy) doesn’t work. 

What more recent studies do show: Autistics who experienced ABA therapy are at high risk to develop PTSD and other lifelong trauma-related conditions. Historically, the autism organizations promoting ABA as a cure or solution have silenced Autistic advocates’ opposition. ABA is also known as gay conversion therapy.

The ‘cure’ for Autistics not born yet is the prevention of birth. 

The ‘cure’ is a choice to terminate a pregnancy based on ‘autism risk.’ The cure is abortion. This is the same ‘cure’ society has for Down Syndrome. 

This is eugenics 2021. Instead of killing Autistics and disabled children in gas chambers or ‘mercy killings’ like in Aktion T4, it’ll happen at the doctor’s office, quietly, one Autistic baby at a time. Different approaches yes, but still eugenics and the extinction of an entire minority group of people.

Fact: You can’t cure Autistics from being Autistic.

Fact: You can’t recover an Autistic from being Autistic.

Fact: You can groom an Autistic to mask and hide their traits. Somewhat. … however, this comes at the expense of the Autistic child, promotes Autistic Burnout (this should not be confused with typical burnout, Autistic Burnout can kill Autistics), and places the Autistic child at high risk for PTSD and other lifelong trauma-related conditions.

[Note: Autism is NOT a disease, but a neurodevelopmental difference and disability.]

Fact: Vaccines Do Not Cause Autism.

Leave a Reply

Fill in your details below or click an icon to log in: Logo

You are commenting using your account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s

This site uses Akismet to reduce spam. Learn how your comment data is processed.

%d bloggers like this: